Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,230,021
-$2,883,271 QoQ
Shares Held
103,280
-13.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#633
of 4,647 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bellevue Group AG holds $668,956,159 across 9 Drug Manufacturers - General names. JNJ ranks #4 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
851,550 | $308,363,285 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
2,158,772 | $272,739,254 | |
| 3 | LLY |
ELI LILLY & Co
|
29,882 | $35,841,370 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
103,280 | $26,230,021 | |
| 5 | MRK |
Merck & Co., Inc.
|
113,061 | $14,528,338 | |
| 6 | ABBV |
AbbVie Inc.
|
40,476 | $10,185,380 | |
| 7 | PFE |
Pfizer Inc
|
38,431 | $925,418 | |
| 8 | BIIB |
Biogen Inc.
|
338 | $73,028 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,230,021 | 103,280 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $29,113,292 | 119,102 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $26,241,260 | 126,800 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $13,870,713 | 74,807 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $10,419,230 | 68,211 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $11,112,772 | 67,009 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $7,890,033 | 54,557 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $8,304,278 | 51,242 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,139,609 | 7,797 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,015,579 | 6,420 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,432,607 | 28,280 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,554,682 | 22,823 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,513,162 | 21,225 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,550,275 | 22,905 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,597,669 | 26,027 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,010,414 | 30,671 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,132,524 | 28,914 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $4,909,271 | 27,700 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,455,614 | 20,200 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $4,925,750 | 30,500 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $5,106,940 | 31,000 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $6,754,785 | 41,100 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $4,406,640 | 28,000 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||